Viking Global Investors L.P., 10% Owner at Urovant Sciences Ltd. (UROV), bought 22,011 shares at $8.30 ($177K) on 2019-06-12, disclosed to the SEC on 2019-06-14.
Open-market purchase of $177k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.30 | 7,500 | $62K | 35.1% |
| 2 | $7.95 | 7,367 | $59K | 33.0% |
| 3 | $7.91 | 7,144 | $57K | 31.9% |
| Total | $8.06 avg | 22,011 | $177K | 100% |
| Filing → |
| ADPT | BUY | 2019-07-02 | $5.0M | — | Filing → |
| UROV | BUY | 2019-06-11 | $177K | — | Filing → |
| UROV | BUY | 2019-06-03 | $278K | — | Filing → |